slotkoers
Shenzhen S.E.
00:00:00 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3,6
CNY
|
-0,28%
|
|
-3,23%
|
-14,69%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
3.795
|
4.989
|
5.592
|
5.675
|
5.013
|
4.989
|
Bedrijfswaarde
1 |
3.895
|
4.809
|
5.900
|
7.098
|
6.462
|
6.321
|
K/w-verhouding
|
107
x
|
117
x
|
59,1
x
|
43,6
x
|
27,7
x
|
26,5
x
|
Dividendrendement
|
0,93%
|
0,24%
|
0,32%
|
0,38%
|
0,5%
|
0,5%
|
Marktkapitalisatie/omzet
|
2,74
x
|
3,41
x
|
3,46
x
|
3,64
x
|
3,1
x
|
3,05
x
|
Bedrijfswaarde/omzet
|
2,81
x
|
3,29
x
|
3,65
x
|
4,55
x
|
3,99
x
|
3,86
x
|
Bedrijfswaarde/EBITDA
|
21
x
|
23,3
x
|
26,2
x
|
19,8
x
|
17,3
x
|
13,5
x
|
Bedrijfswaarde/FCF
|
28,4
x
|
15,3
x
|
-186
x
|
-11,2
x
|
48,8
x
|
21,6
x
|
FCF Yield
|
3,52%
|
6,53%
|
-0,54%
|
-8,93%
|
2,05%
|
4,64%
|
Price to Book
|
1,74
x
|
2,29
x
|
2,48
x
|
2,39
x
|
1,98
x
|
1,85
x
|
Aantal aandelen (in duizenden)
|
1.182.213
|
1.182.213
|
1.182.213
|
1.182.213
|
1.182.213
|
1.182.213
|
Referentieprijs
2 |
3,210
|
4,220
|
4,730
|
4,800
|
4,240
|
4,220
|
Datum van publicatie
|
19/04/19
|
30/03/20
|
19/03/21
|
30/03/22
|
24/03/23
|
24/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.384
|
1.462
|
1.616
|
1.561
|
1.619
|
1.636
|
EBITDA
1 |
185,4
|
206,8
|
225,2
|
358,1
|
373,8
|
468,6
|
Bedrijfsresultaat (EBIT)
1 |
71,81
|
96,57
|
114,5
|
226,6
|
226,6
|
344,8
|
Operationele Marge
|
5,19%
|
6,61%
|
7,08%
|
14,52%
|
13,99%
|
21,08%
|
Resultaat voor belastingen (EBT)
1 |
43,56
|
67,41
|
111,6
|
150,3
|
205,9
|
230,5
|
Nettowinst (verlies)
1 |
38,79
|
42,07
|
94,62
|
130,4
|
180,8
|
188,1
|
Nettomarge
|
2,8%
|
2,88%
|
5,85%
|
8,35%
|
11,16%
|
11,49%
|
WPA
2 |
0,0300
|
0,0360
|
0,0800
|
0,1100
|
0,1530
|
0,1590
|
Free Cash Flow
1 |
137
|
314,3
|
-31,71
|
-634,2
|
132,5
|
293,2
|
FCF-marge
|
9,9%
|
21,5%
|
-1,96%
|
-40,63%
|
8,18%
|
17,92%
|
Kasstroomconversie (ebitda)
|
73,91%
|
151,95%
|
-
|
-
|
35,44%
|
62,57%
|
Kasstroomconversie (nettowinst)
|
353,11%
|
747,05%
|
-
|
-
|
73,26%
|
155,89%
|
Dividend per aandeel
2 |
0,0300
|
0,0100
|
0,0150
|
0,0180
|
0,0210
|
0,0210
|
Datum van publicatie
|
19/04/19
|
30/03/20
|
19/03/21
|
30/03/22
|
24/03/23
|
24/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
99,8
|
-
|
308
|
1.423
|
1.450
|
1.332
|
Nettokaspositie
1 |
-
|
180
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,5382
x
|
-
|
1,367
x
|
3,974
x
|
3,879
x
|
2,842
x
|
Free Cash Flow
1 |
137
|
314
|
-31,7
|
-634
|
132
|
293
|
ROE (netto-inkomsten/eigen vermogen)
|
1,97%
|
2,01%
|
4,23%
|
5,62%
|
7,19%
|
7,21%
|
ROA (netto-inkomsten/totale activa)
|
1,49%
|
2,06%
|
2,34%
|
3,13%
|
2,62%
|
4,17%
|
Totale activa
1 |
2.609
|
2.042
|
4.051
|
4.169
|
6.898
|
4.506
|
Nettoactief per aandeel
2 |
1,840
|
1,840
|
1,910
|
2,010
|
2,140
|
2,280
|
Cashflow per aandeel
2 |
0,5200
|
0,3200
|
0,1900
|
0,3500
|
0,1900
|
0,2000
|
Capex
1 |
45,5
|
32
|
58
|
27,9
|
42,3
|
45,9
|
Capex/omzet
|
3,29%
|
2,19%
|
3,59%
|
1,78%
|
2,61%
|
2,8%
|
Datum van publicatie
|
19/04/19
|
30/03/20
|
19/03/21
|
30/03/22
|
24/03/23
|
24/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -14,69% | 588 mln. | | +22,35% | 44,12 mld. | | +22,22% | 22,61 mld. | | +17,81% | 15,11 mld. | | +15,73% | 13,61 mld. | | +57,91% | 13,34 mld. | | -8,98% | 6,94 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +15,65% | 5,75 mld. |
Generieke geneesmiddelen
|